{"nct_id":"NCT03516981","title":"A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)","status":"COMPLETED","status_verified_date":"2025-06","start_date":"2018-10-01","start_date_type":"ACTUAL","primary_completion_date":"2025-06-13","primary_completion_date_type":"ACTUAL","completion_date":"2025-06-13","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}